Amgen’s stock may see worst day in 24 years as weight loss drug data underwhelms

Amgen’s stock closes off lows to avoid worst day in 24 years as weight-loss-drug data underwhelms

Amgen’s MariTide achieved up to 20% weight loss in a mid-stage trial, but analysts were expecting up to 25%.

Business - MarketWatch - 2 hours ago

Amgen says no concerns around weight loss drug’s bone density data after stock falls

Analysts chewed over early data showing the highest dose of Amgen's MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks.

Business - CNBC - November 13

New Obesity Drug MariTide Helps Patients Lose Up to 20% of Weight, Early Data Shows

The drug, which is named MariTide and delivered in a monthly injection, is some time away from being sold.

Business - The New York Times - 18 hours ago

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other experimental treatments.

Business - CNBC - 17 hours ago

AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors

AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill.

Business - MarketWatch - November 5

Why Thanksgiving may feel different for Americans on weight loss drugs

This may be the first Thanksgiving for millions of Americans who are on GLP-1 agonists like Ozempic, Zepbound or Wegovy.

Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial

The stock, which enjoys the unusual position of having all buy ratings from the 13 analysts offering coverage on FactSet, has been on a tear this year, gaining 270% to date in 2024.

Business - MarketWatch - November 4

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy ...

Business - MarketWatch - November 16

Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 billion proposal from the Biden administration is blessed by ...

Health - ABC News - 11 hours ago

Weight-loss-drug makers’ stocks get a boost from new Biden coverage proposal, but will it hold up?

The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board early Tuesday, after the Biden administration proposed a rule that would ...

Business - MarketWatch - Yesterday

Microsoft's stock has worst day in two years after disappointing forecast

Microsoft's stock fell more than 6% on Thursday after guidance fell short of analysts' estimates.

Business - CNBC - October 31

Nurse’s death linked to approved weight-loss drug

Susan McGowan from North Lanarkshire died two weeks after taking the drug tirzepatide, brand name Mounjaro.

Weight loss drug industry injects wealth into Novo Nordisk home country

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great heft to the economy of Novo Nordisk's home country, Denmark.

Counterfeit weight loss drugs sold online as demand for cheaper options grows

A surge in counterfeit versions of popular weight loss drugs is raising health concerns. U.S. Customs is intercepting fake medications with potentially harmful effects. Tom Hanson reports on the ...

Counterfeit weight loss drugs feed demand for cheaper options

Record demand for Ozempic, Wegovy and other weight loss drugs is fueling a surge of dangerous knockoffs.

Ozempic, Wegovy popularity leads to rise of fake weight loss drugs

The demand for weight loss drugs like Ozempic and Wegovy has led to a flood of fake drugs hitting the market. However, these counterfeit medicines can be harmful to people's health. Tom Hanson has ...

Surging diabetes rate underscores vast opportunity in weight-loss drugs

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according to new data released in The Lancet on World Diabetes Day.

Business - MarketWatch - November 14

Employers Get Pressure to Pay for Drugs Like Wegovy

Eli Lilly and Novo Nordisk representatives get face time with companies in hopes they will cover their weight-loss drugs.

Business - The Wall Street Journal - November 19

Novo Nordisk Launches Wegovy Weight-Loss Drug in China

The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will cost about $193 for a one-month supply of the lowest starter dose.

Business - The Wall Street Journal - November 19

More Large U.S. Employer Health Plans Covering Weight-Loss Drugs

A survey by consulting firm Mercer shows that close to half of U.S. companies with more than 500 employees now cover drugs such as Wegovy, Ozempic, and Zepbound.

Business - Inc. - 6 days ago

Weight-loss drugs can improve kidney health, study finds

Analysis involving more than 85,000 people showed risk of worsening function was reduced by 22%. Weight-loss drugs can reduce the risk of worsening kidney function, kidney failure and dying from ...

World - The Guardian - Yesterday

Biden proposes weight loss drug coverage requirements for Medicare and Medicaid

Weight loss drugs like Wegovy, Zepbound and Ozempic would be covered by Medicare and Medicaid under a Biden administration proposal.

Biden proposes Medicare and Medicaid cover weight-loss drugs for obese Americans

Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday ...

Health - ABC News - 18 hours ago

Biden proposes huge expansion of US weight-loss drug coverage

State-backed insurance programmes would fund drugs for obese patients without separate health conditions

World - Financial Times - Yesterday

Biden proposes Medicare and Medicaid cover weight-loss drugs for 7.4m people

Move aims to tackle US’s chronic obesity problem, but poses a challenge to Trump’s incoming administration. The Biden administration is proposing to make “miracle” weight loss drugs free for ...

World - The Guardian - 21 hours ago

Biden proposes expanded coverage for weight loss drugs under Medicare, Medicaid

The Biden administration has proposed a plan for Medicare and Medicaid to offer coverage for weight loss medications, such as Ozempic and Wegovy.

Politics - NBC News - 20 hours ago

Biden proposes weight loss drug coverage by Medicare, Medicaid

President Biden's proposal for Medicaid and Medicare coverage for weight loss drugs such as Ozempic and Wegovy could draw opposition from the drug industry and President-elect Donald Trump's ...

Why Biden is proposing weight loss drug Medicare, Medicaid coverage

President Biden's proposal to expand Medicaid and Medicare coverage for some weight loss drugs could impact thousands of Americans. CBS News' Alexander Tin breaks down what's known about the ...

Not just for weight loss: Wegovy may help curb alcohol addiction

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA Psychiatry suggests.

Latest in Amgen’s stock may see worst day in 24 years as weight loss drug data underwhelms